Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 12, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$30.6B
sum of reported positions
Reported positions
278
Changes vs prior quarter
285
69 new · 41 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 523 measured positions in 8 quarters, the typical new or larger position finished −4.6 pts against the S&P 500 and 40% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 8.08M | $1.62B | 5.3% | |
| 3.75M | $1.34B | 4.4% | |
| 4.8M | $1.28B | 4.2% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $23.8B | $30.6B |
| Positions | 250 | 278 |
| Biggest line | — | NVIDIA 5% |
| 1.49M |
| $836M |
| 2.7% |
| 2.94M | $795M | 2.6% |
| 2.57M | $745M | 2.4% |
| 355K | $704M | 2.3% |
| 1.56M | $588M | 1.9% |
| 1.41M | $528M | 1.7% |
| 1.92M | $517M | 1.7% |
| 417K | $500M | 1.6% |
| 1.74M | $442M | 1.4% |
| 929K | $413M | 1.3% |
| 677K | $382M | 1.2% |
| 1.05M | $353M | 1.2% |
| 241K | $283M | 0.9% |
| 228K | $263M | 0.9% |
| 762K | $262M | 0.9% |
| 6.15M | $261M | 0.9% |
| 1.7M | $248M | 0.8% |
| 2.21M | $245M | 0.8% |
| 6M | $245M | 0.8% |
| 511K | $244M | 0.8% |
| 1.62M | $244M | 0.8% |
| 331K | $239M | 0.8% |
Apple (AAPL)
3.13M → 2.57M shares (−18%)
Comfort Systems USA (FIX)
621K → 355K shares (−43%)
Microsoft (MSFT)
1.65M → 1.41M shares (−14%)
Howmet Aerospace (HWM)
2.29M → 1.92M shares (−16%)
MKS Instruments (MKSI)
1.05M → 929K shares (−11%)
Vertiv (VRT)
1.92M → 1.05M shares (−45%)
Tapestry, Inc. (TPR)
2.2M → 1.7M shares (−23%)
Lpl Financial (LPLA)
882K → 793K shares (−10%)
Rocket Lab (RKLB)
3.17M → 2.11M shares (−33%)
Amazon (AMZN)
2.28M → 860K shares (−62%)
Natera (NTRA)
755K → 727K shares (−4%)
Semtech (SMTC)
1.28M → 1.13M shares (−12%)
Ametek (AME)
746K → 724K shares (−3%)
Dutch Bros Inc. (BROS)
2.31M → 2.18M shares (−6%)
Vaxcyte (PCVX)
3.65M → 2.47M shares (−32%)
Globe Life (GL)
842K → 771K shares (−9%)
Legend Biotech (LEGN)
5.76M → 4.43M shares (−23%)
Everpure (P)
1.87M → 1.61M shares (−14%)
Astera Labs (ALAB)
860K → 249K shares (−71%)
Coherent Corp. (COHR)
397K → 291K shares (−27%)
Legence (LGN)
1.86M → 1.34M shares (−28%)
Onto Innovation (ONTO)
327K → 299K shares (−8%)
Cencora (COR)
437K → 400K shares (−8%)
Revolution Medicines (RVMD)
1.56M → 601K shares (−61%)
Live Nation Entertainment (LYV)
811K → 591K shares (−27%)
